Signal active
Investment Firm
Overview
Hamilton Lane is a private markets investment firm that serves institutional and private wealth investors worldwide. As of December 31, 2022, Hamilton Lane had $831.9 billion in assets under management and supervision, with $107.5 billion in discretionary assets and $724.4 billion in non-discretionary assets. Hamilton Lane specializes in developing adaptable investment programs that give clients access to a broad range of private market strategies, sectors, and geographies.
Highlights
1991
Financial Services
501-1000
54
14
8
Late Stage Venture, Early Stage Venture, Private Equity, Seed
Private Equity Firm, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
Hamilton Lane, established in 1991 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Private Equity, Seed investments across Enterprise Software, Education, Professional Services, Finance, Financial Services, Asset Management, Aerospace, Management Consulting, Venture Capital, Virtualization. The organization boasts a portfolio of 53 investments, with an average round size of $77.8M and 8 successful exits. Their recent investments include Schoolnet, Ascend Venture Group, The Carlyle Group, New York State Common Retirement Fund, Partnership Fund for New York City. The highest investment round they participated in was $513.8B. Among their most notable exits are Schoolnet and Ascend Venture Group. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
54
5
14
8
Investments
54
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
May 01, 2024 | - | - | 47.0M |
May 21, 2024 | Novata | Information Services | null |
Jun 26, 2024 | Daphne | Impact Investing | null |
Jul 17, 2024 | Cosette Pharmaceuticals | Biotechnology | null |
Exits
8
Funding Timeline
54
0
25
Funding Rounds
54
Hamilton Lane has raised 54 rounds. Their latest funding was raised on Jul 17, 2024 from a Secondary Market - Cosette Pharmaceuticals round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
May 01, 2024 | Series C - Securitize | - | 47.0M | - |
May 21, 2024 | Venture Round - Novata | - | 0 | - |
Jun 26, 2024 | Seed Round - Daphne | - | 0 | - |
Jul 17, 2024 | Secondary Market - Cosette Pharmaceuticals | - | 0 | - |
Investors
2
Investor Name | Lead Investor | Funding Round | Money Raised |
---|---|---|---|
- | No | Post-IPO Equity - Hamilton Lane | 51.7M |
- | No | Post-IPO Equity - Hamilton Lane | 210.0M |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.